Cost determinants in management of brain arteriovenous malformations
- 24 Downloads
There is little data on the cost of treating brain arteriovenous malformations (AVMs). The goal of this study then is to identify cost determinants in multimodal management of brain AVMs.
One hundred forty patients with brain AVMs prospectively enrolled in the UCSF brain AVM registry and treated between 2012 and 2015 were included in the study. Patient and AVM characteristics, treatment type, and length of stay and radiographic evidence of obliteration were collected from the registry. We then calculated the cost of all inpatient and outpatient encounters, interventions, and imaging attributable to the AVM. We used generalized linear models to test whether there was an association between patient and AVM characteristics, treatment type, and cost and length of stay. We tested whether the proportion of patients with radiographic evidence of obliteration differed between treatment modalities using Fisher’s exact test.
The overall median cost of treatment and interquartile range was $77,865 (49,566–107,448). Surgery with preoperative embolization was the costliest treatment at $91,948 (79,914–140,600), while radiosurgery was the least at $20,917 (13,915–35,583). In multi-predictor analyses, hemorrhage, Spetzler-Martin grade, and treatment type were significant predictors of cost. Patients who had surgery had significantly higher rates of obliteration compared with radiosurgery patients.
Hemorrhage, AVM grade, and treatment modality are significant cost determinants in AVM management. Surgery with preoperative embolization was the costliest treatment and radiosurgery the least; however, surgical cases had significantly higher rates of obliteration.
KeywordsBrain arteriovenous malformation Cost Cost-effectiveness
Compliance with ethical standards
The study was approved by the University of California San Francisco Committee on Human Research and conducted in compliance with Health Insurance Portability and Accountability Act regulations.
Conflict of interest
The authors declare that they have no conflict of interest.
For this retrospective study, formal consent is not required
- 2.Caruso JP, Moosa S, Fezeu F, Ramesh A, Sheehan JP (2015) A cost comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 22:184–188. https://doi.org/10.1016/j.jocn.2014.08.012 CrossRefGoogle Scholar
- 5.Kano H, Lunsford LD, Flickinger JC, Yang HC, Flannery TJ, Awan NR, Niranjan A, Novotny J Jr, Kondziolka D (2012) Stereotactic radiosurgery for arteriovenous malformations, Part 1: management of Spetzler-Martin grade I and II arteriovenous malformations. Journal of neurosurgery 116:11–20. https://doi.org/10.3171/2011.9.jns101740 CrossRefPubMedGoogle Scholar
- 9.Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, Alphs H, Ladd SC, Warlow C, Wardlaw JM, Al-Shahi Salman R (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (Clinical research ed) 339:b3016. https://doi.org/10.1136/bmj.b3016 CrossRefGoogle Scholar
- 14.van Rooij WJ, Jacobs S, Sluzewski M, van der Pol B, Beute GN, Sprengers ME (2012) Curative embolization of brain arteriovenous malformations with onyx: patient selection, embolization technique, and results. AJNR American journal of neuroradiology 33:1299–1304. https://doi.org/10.3174/ajnr.A2947 CrossRefPubMedGoogle Scholar
- 15.Wellis G, Nagel R, Vollmar C, Steiger HJ (2003) Direct costs of microsurgical management of radiosurgically amenable intracranial pathology in Germany: an analysis of meningiomas, acoustic neuromas, metastases and arteriovenous malformations of less than 3 cm in diameter. Acta neurochirurgica 145:249–255. https://doi.org/10.1007/s00701-003-0007-4 CrossRefPubMedGoogle Scholar